Clinical Study onErxian Decoction Combined with Elcatonin in the Treatment of Postmenopausal Osteoporosis
10.3969/j.issn.1005-5304.2016.06.007
- VernacularTitle:二仙汤联合依降钙素治疗绝经期妇女骨质疏松症临床研究
- Author:
Binglin YE
;
Shenghua LI
;
Shuling LI
;
Xiangfu WANG
;
Fengqi SUN
;
Yuxia WEN
- Publication Type:Journal Article
- Keywords:
osteoporosis;
Erxian Decoction;
elcatonin;
menopausal women
- From:
Chinese Journal of Information on Traditional Chinese Medicine
2016;23(6):23-26
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical efficacy ofErxian Decoction combined with elcatonin for the treatment of postmenopausal osteoporosis.Methods Eighty cases of female patients with postmenopausal osteoporosis were randomly divided into treatment group and control group, 40 cases in each group. The control group received intramuscular injections elcatonin treatment, and the treatment group received oralErxian Decoction on the basis of the treatment of the control group, for 12 weeks. The main clinical symptom score, VAS score and bone mineral density (BMD) of L2-L4 and in the tibia of the two groups were observed before and after treatment to assess the therapeutic effect.Results After treatment, VAS scores of the two groups were significantly lower (P<0.05). The total effective rate of the treatment group was 92.5% (37/40); the control group was 75.0 (30/40), with statistical significance (P<0.05). The treatment group was significantly better than the control group in main symptom scores, especially in improving body symptoms (P<0.05). BMD of the treatment group was significantly higher than the control group.ConclusionErxian Decoction combined with elcatonin therapy for postmenopausal women with osteoporosis can significantly improve clinical symptoms and increase BMD.
